[1] 沈铿, 郎景和. 妇科肿瘤临床决策[M].北京:人民卫生出版社,2009:290-293. [2] Bristow R E,Chi D S.Platinum-based neoadjuvant chemotherapy and interval surgical cytoreduction for advanced ovarian cancer:a meta-analysis[J].Gynecologic Oncology,2006,103(3):1070-1076. [3] 张琴.晚期卵巢上皮性癌治疗与预后因素分析[D].南宁:广西医科大学,2011. [4] Makasian G D,Decker D G,Webb M J.Histology of epithelial tumors of theory:clinical usefulness and prognostic significance of the histologic classification and grading[J].Semin Oncol,1975,2(3) :191-201. [5] Taskm S,Güngr M,Ortac F,et al.Neoadjuvant chemotherapy equalizes the optimal cytoreduction rate to primary surgery without improving survival in advanced ovarian cancer[J].Archives of gynecology and obstetrics,2013,288(6):1399-1403. [6] Mueller J J,Zhou Q C,Iasonos A,et al.Neoadjuvant chemotherapy and primary debulking surgery utilization for advanced-stage ovarian cancer at a comprehensive cancer center[J].Gynecologic Oncology,2016,140(3):436-442. [7] Kang S,Nam B H.Does neoadjuvant chemotherapy increase optimal cytoreduction rate in advanced ovarian cancer? Meta-analysis of 21 studies[J].Annals of surgical oncology,2009,16(8):2315-2320. [8] Rauh-Hain J A,Nitschmann C C,Worley M J Jr,et al.Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma[J].Gynecologic Oncology,2013,129(1):63-68. [9] Abdel-Azeez H A,Labib H A,Sharaf S M,et al.HE4 and mesothelin: novel biomarkers of ovarian carcinoma in patients with pelvic masses[J].Asian Pac J Cancer Prev,2010,11(1):111-116. |
[1] |
WANG Qinghua, WANG Feng, PANG Zehui, CHEN Qiangpu, CHENG Yu, QU Guiwu, GUAN Qinghai. Effect of ecological immune enteral nutrition support on prognosis and liver function of patients with severe acute pancreatitis[J]. 滨州医学院学报, 2019, 42(4): 257-259. |
[2] |
. [J]. 滨州医学院学报, 2019, 42(2): 144-145. |
[3] |
. [J]. 滨州医学院学报, 2019, 42(1): 60-61. |
[4] |
DONG Jingmin, XU Kun, BIAN Jia, WANG Hongxia, REN Wen, SU Wenjing, QU Zhengwei, ZHONG Xiaofei. Effect of dynamic enhanced magnetic resonance imaging and biological factors in neoadjuvant chemotherapyfor invasive ductal carcinoma of breast[J]. 滨州医学院学报, 2018, 41(4): 284-288. |
[5] |
LIU Yong, LI Jianmin. Clinical study of LVIS stent in the treatment of intracranial aneurysms[J]. 滨州医学院学报, 2018, 41(3): 165-167. |
[6] |
XU Jing, GE Ruli, HOU Yiwei. Effect of mNGF in the treatment and levels of serum MBP,NSE,and VEGF in patients with cerebral infarction[J]. 滨州医学院学报, 2018, 41(3): 171-173. |
|
|
|